14:58 , Mar 8, 2017 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Lung cancer Patient sample and mouse studies suggest inhibiting the CD109 - JAK-1 - STAT3 axis could help treat metastatic lung cancer. In patients, high levels of CD109 in primary tumors correlated with poor...